BFO
ARKG icon

Biltmore Family Office’s ARK Genomic Revolution ETF ARKG Stock Holding History

Biltmore Family Office’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-35
Closed -$896 – 267
2024
Q3 		$896 Hold
35
– – ﹤0.01% 264
2024
Q2 		$822 Hold
35
– – ﹤0.01% 243
2024
Q1 		$1.01K Hold
35
– – ﹤0.01% 229
2023
Q4 		$1.15K Hold
35
– – ﹤0.01% 224
2023
Q3 		$975 Buy
+35
New +$1.14K ﹤0.01% 233

Other funds holding ARKG

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Biltmore Family Office's ARKG Position: Q4 2024 in Review

Biltmore Family Office sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2024, closing a stake of 35 shares — an estimated $896 sold.

Biltmore Family Office first reported a position in ARKG in Q3 2023 and held it in 5 quarters. The position peaked at $1.15K in Q4 2023. 238 funds tracked by Wall St. Rank hold ARKG as of Q4 2024.

  • Biltmore Family Office reported no remaining ARK Genomic Revolution ETF position as of Q4 2024 after selling out during the quarter.
  • Biltmore Family Office sold 35 ARK Genomic Revolution ETF shares in Q4 2024, an estimated $896.
  • Biltmore Family Office first reported a position in ARK Genomic Revolution ETF in Q3 2023 and held it in 5 quarters.
  • Biltmore Family Office's ARK Genomic Revolution ETF position peaked at $1.15K in Q4 2023.
  • 238 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2024.

Based on Biltmore Family Office's 13F filing for Q4 2024, filed 12 Feb 2025.